Relieving pain

Relieving pain is a therapeutic indication and clinical outcome rather than a specific molecular target such as a protein, receptor, or enzyme (Mogilski et al., 2020) [7]. It refers to the physiological process of reducing or eliminating the sensation of pain, medically termed analgesia (Fierce Biotech, 2022) [1]. In drug discovery, pain relief is achieved by modulating various distinct biological targets such as the mu-opioid receptor, cyclooxygenase (COX) enzymes, and ion channels like TRPV1 and Nav1.7 (Pain Physician, 2020) [8]. Because "Relieving pain" describes a broad clinical effect and not a single molecule, it lacks a unique molecular classification, biological function, or gene association (PMC11520199) [3]. Consequently, it is categorized as a therapeutic goal or pharmacological effect rather than a discrete target for drug development (MDPI, 2021) [9]. Research in this area focuses on the specific proteins involved in the transmission and processing of noxious stimuli to provide effective analgesic therapy (PMC11306355) [6].

Other names

AnalgesiaPain reliefAntinociceptionPain management

Not applicable as this refers to a therapeutic indication rather than a molecular target.